Patient Comfort with Yellow (577 nm) vs. Green (532 nm) Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy

Patient Comfort ◽

532 Nm

Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy

Case Medical Research ◽

10.31525/ct1-nct04278417 ◽

2020 ◽

Author(s):

Keyword(s):

Diabetic Retinopathy ◽

Efficacy And Safety ◽

Photocoagulation Laser

Faculty Opinions recommendation of Panretinal photocoagulation for proliferative diabetic retinopathy: pattern scan laser versus argon laser.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13696956.15111056 ◽

2012 ◽

Author(s):

George Williams ◽

Emmanuel Chang

Keyword(s):

Diabetic Retinopathy ◽

Argon Laser ◽

Pattern Scan Laser

Faculty Opinions recommendation of Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727273826.793539313 ◽

2017 ◽

Author(s):

Quan Dong Nguyen

Keyword(s):

Diabetic Retinopathy ◽

Factors Associated

Intravitreal anti‐vascular endothelial growth factors, panretinal photocoagulation and combined treatment for proliferative diabetic retinopathy: a systematic review and network meta‐analysis

Acta Ophthalmologica ◽

10.1111/aos.14681 ◽

2020 ◽

Author(s):

Matteo Fallico ◽

Andrea Maugeri ◽

Andrew Lotery ◽

Antonio Longo ◽

Vincenza Bonfiglio ◽

...

Keyword(s):

Systematic Review ◽

Diabetic Retinopathy ◽

Growth Factors ◽

Meta Analysis ◽

Combined Treatment ◽

Vascular Endothelial Growth Factors ◽

Vascular Endothelial ◽

Endothelial Growth Factors

Long-term review of driving potential following bilateral panretinal photocoagulation for proliferative diabetic retinopathy

Diabetic Medicine ◽

10.1111/j.1464-5491.2008.02623.x ◽

2009 ◽

Vol 26 (1) ◽

pp. 97-99 ◽

Cited By ~ 7

Author(s):

S. A. Vernon ◽

J. Bhagey ◽

M. Boraik ◽

H. El-Defrawy

Keyword(s):

Diabetic Retinopathy ◽

Driving Potential

Structural and Functional Assessment of Macula in Patients with High-Risk Proliferative Diabetic Retinopathy Submitted to Panretinal Photocoagulation and Associated Intravitreal Bevacizumab Injections: A Comparative, Randomised, Controlled Trial

Ophthalmologica ◽

10.1159/000348605 ◽

2013 ◽

Vol 230 (1) ◽

pp. 1-8 ◽

Cited By ~ 8

Author(s):

Rony Carlos Preti ◽

Lisa Mariel Vasquez Ramirez ◽

Mário Luiz Ribeiro Monteiro ◽

David E. Pelayes ◽

Walter Yukihiko Takahashi

Keyword(s):

Diabetic Retinopathy ◽

High Risk ◽

Randomised Controlled Trial ◽

Functional Assessment ◽

Controlled Trial ◽

Intravitreal Bevacizumab ◽

Randomised Controlled

Efficacy of bevacizumab for vitreous haemorrhage in proliferative diabetic retinopathy with prior complete panretinal photocoagulation

Eye ◽

10.1038/s41433-020-01384-y ◽

2021 ◽

Author(s):

Young Joo Park ◽

Jeeyun Ahn ◽

Tae Wan Kim ◽

Sang Jun Park ◽

Kwangsic Joo ◽

...

Keyword(s):

Diabetic Retinopathy ◽

Vitreous Haemorrhage ◽

Panretinal Photocoagulation

Cost Analysis of Intravitreal Aflibercept vs Vitrectomy With Panretinal Photocoagulation for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy

JAMA Ophthalmology ◽

10.1001/jamaophthalmol.2021.1565 ◽

2021 ◽

Author(s):

Benjamin K. Young ◽

Mark W. Johnson ◽

Thomas J. Wubben

Keyword(s):

Diabetic Retinopathy ◽

Cost Analysis ◽

Vitreous Hemorrhage ◽

Intravitreal Aflibercept

Repeated intravitreal bevacizumab (Avastin®) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation

Acta Ophthalmologica ◽

10.1111/j.1755-3768.2009.01622.x ◽

2009 ◽

Vol 89 (1) ◽

pp. 76-81 ◽

Cited By ~ 26

Author(s):

Gerald Schmidinger ◽

Noemi Maar ◽

Matthias Bolz ◽

Christoph Scholda ◽

Ursula Schmidt-Erfurth

Keyword(s):

Diabetic Retinopathy ◽

Intravitreal Bevacizumab ◽

Panretinal Photocoagulation

Clinical efficacy and acceptability of panretinal photocoagulation combined with conbercept for patients with proliferative diabetic retinopathy

Medicine ◽

10.1097/md.0000000000025611 ◽

2021 ◽

Vol 100 (17) ◽

pp. e25611

Author(s):

Liangyu Wang ◽

Zhaoli Chen ◽

Xiaoxue Wang

Keyword(s):

Diabetic Retinopathy ◽

Clinical Efficacy ◽

Panretinal Photocoagulation